{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:22:05Z","timestamp":1769001725847,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Esophagus"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s10388-024-01068-6","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T17:01:50Z","timestamp":1717693310000},"page":"484-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of proton-based definitive chemoradiotherapy and surgery-based therapy for esophageal squamous cell carcinoma: a multi-center retrospective Japanese cohort study"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-4324","authenticated-orcid":false,"given":"Koichi","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Toyozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Noma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiro","family":"Hojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Tamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Azami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Nabeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Araya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunao","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazushi","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisahiro","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"key":"1068_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1068_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1245\/s10434-011-2049-9","volume":"19","author":"N Ando","year":"2012","unstructured":"Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68\u201374.","journal-title":"Ann Surg Oncol"},{"key":"1068_CR3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ijrobp.2010.06.033","volume":"81","author":"K Kato","year":"2011","unstructured":"Kato K, Muro K, Minashi K, et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys. 2011;81:684\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1068_CR4","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/jjco\/hyx040","volume":"47","author":"M Nomura","year":"2017","unstructured":"Nomura M, Kato K, Ando N, et al. Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II\/III esophageal squamous cell carcinoma (JCOG1406-A). Jpn J Clin Oncol. 2017;47:480\u20136.","journal-title":"Jpn J Clin Oncol"},{"key":"1068_CR5","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3390\/cancers6042356","volume":"6","author":"TC Ling","year":"2014","unstructured":"Ling TC, Slater JM, Nookala P, et al. Analysis of intensity-modulated radiation therapy (IMRT), proton and 3D conformal radiotherapy (3D-CRT) for reducing perioperative cardiopulmonary complications in esophageal cancer patients. Cancers (Basel). 2014;6:2356\u201368.","journal-title":"Cancers (Basel)"},{"key":"1068_CR6","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1007\/s10147-021-01981-1","volume":"26","author":"K Ogawa","year":"2021","unstructured":"Ogawa K, Ishikawa H, Hisakura K, et al. Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma. Int J Clin Oncol. 2021;26:1856\u201363.","journal-title":"Int J Clin Oncol"},{"key":"1068_CR7","volume-title":"TNM classification of malignant tumours","author":"JD Brierley","year":"2016","unstructured":"Brierley JD, Gospodarowicz MKWC. TNM classification of malignant tumours. 8th ed. Oxford: Wiley-Blackwell; 2016.","edition":"8"},{"key":"1068_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10388-023-00993-2","volume":"20","author":"Y Kitagawa","year":"2023","unstructured":"Kitagawa Y, Ishihara R, Oyama T, et al. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 1. Esophagus. 2023;20:343\u201372.","journal-title":"Esophagus"},{"key":"1068_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/jrr\/rrv001","volume":"56","author":"H Makishima","year":"2015","unstructured":"Makishima H, Ishikawa H, Terunuma T, et al. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis. J Radiat Res. 2015;56:568\u201376.","journal-title":"J Radiat Res"},{"key":"1068_CR10","doi-asserted-by":"publisher","first-page":"i16","DOI":"10.1093\/jrr\/rrad012","volume":"64","author":"S Tokumaru","year":"2023","unstructured":"Tokumaru S, Ishikawa H, Soejima T, et al. Analysis of particle therapy registries based on a unified treatment policy for esophageal cancer. J Radiat Res. 2023;64:i16\u201324.","journal-title":"J Radiat Res"},{"key":"1068_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00066-010-2079-4","volume":"186","author":"M Mizumoto","year":"2010","unstructured":"Mizumoto M, Sugahara S, Nakayama H, et al. Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlentherapie und Onkol. 2010;186:482\u20138.","journal-title":"Strahlentherapie und Onkol"},{"key":"1068_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"key":"1068_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-018-0641-9","volume":"16","author":"Y Kitagawa","year":"2019","unstructured":"Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1. Esophagus. 2019;16:1\u201324.","journal-title":"Esophagus"},{"key":"1068_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10388-018-0642-8","volume":"16","author":"Y Kitagawa","year":"2019","unstructured":"Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus. 2019;16:25\u201343.","journal-title":"Esophagus"},{"key":"1068_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","volume":"113","author":"F Li","year":"2018","unstructured":"Li F, Morgan KL, Statistical AMZJ of the A, 2018. Balancing covariates via propensity score weighting. J Am Stat Assoc. 2018;113:390\u2013400.","journal-title":"J Am Stat Assoc"},{"key":"1068_CR16","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/jama.2020.7819","volume":"323","author":"LE Thomas","year":"2020","unstructured":"Thomas LE, Li F, Pencina MJ. Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial. J Am Med Assoc. 2020;323:2417\u20138.","journal-title":"J Am Med Assoc"},{"key":"1068_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bjsopen\/zrac125","volume":"6","author":"SK Kamarajah","year":"2022","unstructured":"Kamarajah SK, Evans RPT, Griffiths EA, et al. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by radical surgery for locally advanced oesophageal squamous cell carcinoma: meta-analysis. BJS Open. 2022;6:1\u20138.","journal-title":"BJS Open"},{"key":"1068_CR18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1200\/JCO.19.02503","volume":"38","author":"SH Lin","year":"2020","unstructured":"Lin SH, Hobbs BP, Verma V, et al. Randomized Phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer. J Clin Oncol. 2020;38:1569\u201379.","journal-title":"J Clin Oncol"},{"key":"1068_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijrobp.2017.06.2450","volume":"99","author":"M Xi","year":"2017","unstructured":"Xi M, Xu C, Liao Z, et al. Comparative outcomes after definitive chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for esophageal cancer: a retrospective, single-institutional analysis. Int J Radiat Oncol Biol Phys. 2017;99:667\u201376.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1068_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ijrobp.2022.07.007","volume":"114","author":"H Takeuchi","year":"2022","unstructured":"Takeuchi H, Ito Y, Machida R, et al. A single-arm confirmatory study of definitive chemoradiation therapy including salvage treatment for clinical stage II\/III esophageal squamous cell carcinoma (JCOG0909 Study). Int J Radiat Oncol Biol Phys. 2022;114:454\u201362.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1068_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10388-022-00962-1","volume":"20","author":"S Matsuda","year":"2023","unstructured":"Matsuda S, Kitagawa Y, Kawakubo H, et al. A nationwide validation of the prognostic impact of pathological response and the distribution of recurrence patterns in responders after neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Esophagus. 2023;20:205\u201314.","journal-title":"Esophagus"},{"key":"1068_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.annonc.2022.10.508","volume":"34","author":"H Tang","year":"2023","unstructured":"Tang H, Wang H, Fang Y, et al. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial. Ann Oncol. 2023;34:163\u201372.","journal-title":"Ann Oncol"},{"key":"1068_CR23","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1159\/000527196","volume":"100","author":"T Sugase","year":"2022","unstructured":"Sugase T, Sugimura K, Kanemura T, et al. Recurrence pattern comparing preoperative chemoradiotherapy and preoperative chemotherapy with docetaxel plus 5-fluorouracil and cisplatin for advanced esophageal cancer. Oncology. 2022;100:655\u2013755.","journal-title":"Oncology"},{"key":"1068_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.radonc.2017.06.019","volume":"124","author":"M Xi","year":"2017","unstructured":"Xi M, Xu C, Liao Z, et al. The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol. 2017;124:318\u201324.","journal-title":"Radiother Oncol"}],"updated-by":[{"DOI":"10.1007\/s10388-024-01071-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000}}],"container-title":["Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-024-01068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10388-024-01068-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-024-01068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T12:17:45Z","timestamp":1726661865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10388-024-01068-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1068"],"URL":"https:\/\/doi.org\/10.1007\/s10388-024-01068-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10388-024-01071-x","asserted-by":"object"}]},"ISSN":["1612-9059","1612-9067"],"issn-type":[{"value":"1612-9059","type":"print"},{"value":"1612-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10388-024-01071-x","URL":"https:\/\/doi.org\/10.1007\/s10388-024-01071-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"There are no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}